Report
Eurofins : Further clarifications on biopharma – a slightly excessive market reaction – TP adjusted to € 55 vs € 58
>Main takeaway from the conference call: explanation for the decline in the Biopharma division - The group held a conference call yesterday at 3.00pm and the share closed down -11.2%. Although the market sanction looks a bit harsh, it can be explained by the accumulation of several negative points, despite a broadly satisfactory performance. Our main takeaways are as follow: Further details on the biopharma division: growth in North America was more moderate, d...
Underlying
Eurofins Scientific Societe Europeenne
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Geoffroy Michalet
Other Reports on these Companies
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.